FDA NDC Directory · JSON-LD · Markdown
NDC 25021-179 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
| Labeler / Manufacturer | Sagent Pharmaceuticals |
|---|---|
| Marketing category | New Drug Application (innovator) · App NDA208385 |
| Dosage form / route | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS |
| Active ingredients | DAPTOMYCIN (350 mg/7mL) |
| Marketing started | 20180115 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).